Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 2/20 | 0.39 |
| ▸ | PRMT6 | Q96LA8 | 2/20 | 0.39 |
| ▸ | PRMT8 | Q9NR22 | 2/20 | 0.39 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.39 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA6 | P23280 | 2/20 | 0.38 |
| ▸ | CA7 | P43166 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA3 | P07451 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6131298 | 1.00 | CARM1 (0.39) | CARM1PRMT6PRMT8PRMT3PRMT1 | |
| SCHEMBL341303 | 1.00 | — | — | |
| SCHEMBL16948506 | 1.00 | CARM1 (0.39) | CARM1PRMT6PRMT8PRMT3PRMT1 | |
| Hydrochloric Acid SCHEMBL23478121 | 0.96 | KDM4E (0.41) | CARM1PRMT6PRMT8PRMT3PRMT1 | |
| SCHEMBL18608790 | 0.89 | CYP2C19 (0.50) | LMNATDP1ALDH1A1CA12CA6 | |
| SCHEMBL5173879 | 0.86 | — | — | |
| SCHEMBL18870232 | 0.86 | EPHX1 (0.50) | LMNATDP1ALDH1A1CA12CA6 | |
| SCHEMBL21003492 | 0.86 | CYP2C19 (0.56) | CARM1PRMT6PRMT8PRMT3PRMT1 | |
| SCHEMBL18372444 | 0.86 | EPHX1 (0.43) | CARM1PRMT6PRMT8PRMT3PRMT1 | |
| SCHEMBL16342225 | 0.86 | EPHX1 (0.43) | CARM1PRMT6PRMT8PRMT3PRMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0058505-B1 | PREPARATION OF ESTERS CONTAINING AN ALPHA-CYANO GROUP IN THE ALCOHOL PORTION OF THE ESTERS | FMC Corporation (US) | 1985-05-29 | — | — | EP | claimed |
| US-11772085-B2 | Far superior oxidation catalysts based on macrocyclic compounds | CARNEGIE MELLON UNIVERSITY (US) | 2023-10-03 | — | — | US | disclosed |
| WO-2023130021-A1 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES WITH IMPROVED DELIVERY PROPERTIES | PHIO PHARMACEUTICALS CORP. (US) | 2023-07-06 | — | — | WO | disclosed |
| WO-2023022926-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2023-02-23 | — | — | WO | disclosed |
| US-11090395-B2 | Composition for cross talk between estrogen receptors and cannabinoid receptors | SeeCure Taiwan Co., Ltd. (TW) | 2021-08-17 | — | — | US | disclosed |
| EP-3862005-A1 | NUCLEIC ACID MOLECULES TARGETING SUPEROXIDE DISMUTASE 1 (SOD1) | Phio Pharmaceuticals Corp. (US) | 2021-08-11 | — | — | EP | disclosed |
| US-11078413-B2 | Organic-inorganic hybrid perovskites, devices, and methods | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2021-08-03 | — | — | US | disclosed |
| US-20210196655-A1 | COMPOSITION FOR CROSS TALK BETWEEN ESTROGEN RECEPTORS AND CANNABINOID RECEPTORS | SeeCure Taiwan Co., Ltd. (TW) | 2021-07-01 | — | — | US | disclosed |
| EP-3512865-B1 | ESTERS OF 3-POLYAMINE DERIVATIVES OF BILE ACIDS FOR THE TREATMENT OF INFECTIONS | VIRBAC (FR) | 2021-05-05 | — | — | EP | disclosed |
| US-20210032273-A1 | Methods of Making Metal Halide Perovskites | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2021-02-04 | — | — | US | disclosed |
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-19 | — | — | US | disclosed |
| US-8048982-B2 | Method for producing aromatic compound polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-11-01 | — | — | US | disclosed |
| WO-2011107512-A1 | THE USE OF LINEAR TRIETHYLENTETRAMINE AS CURING AGENT FOR EPOXY RESINS | BASF SE (DE) | 2011-09-09 | — | — | WO | disclosed |
| US-20110052673-A1 | THERAPEUTIC COMPOSITIONS | SHIRE HUMAN GENETIC THERAPIES, INC. | 2011-03-03 | — | — | US | disclosed |
| WO-2010146009-A1 | METHYL-SUBSTITUTED TETA COMPOUNDS | BASF SE (DE) | 2010-12-23 | — | — | WO | disclosed |
| EP-2241548-A1 | Vanadium di-nuclear complex | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| EP-2241547-A1 | Method for producing aromatic compound polymer | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-15 | — | — | US | disclosed |
| US-7354568-B1 | Magnetic resonance imaging agents for the detection of physiological agents | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2008-04-08 | — | — | US | disclosed |
| EP-1767560-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | Sumitomo Chemical Company, Limited (JP) | 2007-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11090395-B2 | Composition for cross talk between estrogen receptors and cannabinoid receptors | GPER1, ESR1, CNR1 | CARM1 4107/4885PRMT6 3909/4885PRMT8 2480/4885 |
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | PAH, MAOA, AHR | CARM1 1467/4885PRMT6 1699/4885PRMT8 899/4885 |
| US-20210032273-A1 | Methods of Making Metal Halide Perovskites | SOD1, HCN4, KCND2 | CARM1 1238/4885PRMT6 1211/4885PRMT8 2707/4885 |
| US-11772085-B2 | Far superior oxidation catalysts based on macrocyclic compounds | SOD1, ME3, ME2 | CARM1 2303/4885PRMT6 1831/4885PRMT8 1265/4885 |
| US-11078413-B2 | Organic-inorganic hybrid perovskites, devices, and methods | TYR, HCN4, BMI1 | CARM1 3089/4885PRMT6 3642/4885PRMT8 4078/4885 |
| US-20110052673-A1 | THERAPEUTIC COMPOSITIONS | PHOSPHO1, SGMS1, APOB | CARM1 911/4885PRMT6 211/4885PRMT8 641/4885 |
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | PAH, MAOA, AHR | CARM1 1534/4885PRMT6 1727/4885PRMT8 942/4885 |
| US-20210196655-A1 | COMPOSITION FOR CROSS TALK BETWEEN ESTROGEN RECEPTORS AND CANNABINOID RECEPTORS | GPER1, ESR1, CNR1 | CARM1 4107/4885PRMT6 3909/4885PRMT8 2480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.